As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
HONG KONG SAR - EQS Newswire - 22 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio", the "Company", together with its subsidiaries, the "Group")
